1. Fate and PPARγ and STATs-driven effects of the mitochondrial complex I inhibitor tebufenpyrad in liver cells revealed with multi-omics
- Author
-
Thibaut Léger, Patrick Balaguer, Ludovic Le Hégarat, Valérie Fessard, Laboratoire de Fougères - ANSES, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), and Chiffoleau, Emmanuelle
- Subjects
Health, Toxicology and Mutagenesis ,hépatocyte ,MESH: Hepatocytes ,Adenosine Triphosphate ,cell biology ,MESH: Adenosine Triphosphate ,toxicité ,protéomique ,Waste Management and Disposal ,proteomic ,inhibiteur du complexe respiratoire mitochondrial I ,MESH: Proteasome Endopeptidase Complex ,Fatty Acids ,liver cell ,MESH: STAT3 Transcription Factor ,Pollution ,Lipids ,metabolomics ,MESH: Interleukin-6 / metabolism ,MESH: Fatty Acids ,[SDV.TOX] Life Sciences [q-bio]/Toxicology ,STAT Transcription Factors ,Liver ,[SDV.TOX]Life Sciences [q-bio]/Toxicology ,métabolomique ,toxicology ,STAT3 Transcription Factor ,Proteasome Endopeptidase Complex ,Environmental Engineering ,biologie cellulaire ,lignée cellulaire HepaRG ,mitochondrial respiratory complexe I inhibitor ,Mitochondrial Proteins ,HepaRG cell line ,hepatocyte ,Environmental Chemistry ,Animals ,Humans ,MESH: Pesticides ,Pesticides ,pesticide ,cellule hépatique ,Interleukin-6 ,toxicity ,toxicologie ,MESH: STAT Transcription Factors ,Rats ,PPAR gamma ,MESH: PPAR gamma ,Hepatocytes - Abstract
Complete proteomic datasets are available in the PRIDE partner repository (Perez-Riverol et al., 2019) under identification numbers: PXD030822 and 10.6019/PXD030822 for HepaRG cells, PXD031045 and 10.6019/PXD031045 for HepaRG culture media, PXD030887 and 10.6019/PXD030887 for PHHs, and PXD030892 and 10.6019/PXD030892 for PRHs. Metabolomic data are available in the MetaboLights repository (Haug et al., 2020) under the identification number: www.ebi.ac.uk/metabolights/MTBLS4063.; International audience; The biological effects of the pesticide and mitochondrial complex I inhibitor tebufenpyrad (TEBU) on liver cells were investigated by combining proteomics and metabolomics. Both cell culture media and cellular lysates were analyzed in dose-response and kinetic experiments on the HepaRG cell line. Responses were compared with those obtained on primary human and rat hepatocytes. A multitude of phase I and II metabolites (>80) mainly common to HepaRG cells and primary hepatocytes and an increase in metabolization enzymes were observed. Synthesis of mitochondrion and oxidative phosphorylation complex constituents, fatty acid oxidation, and cellular uptake of lipids were induced to compensate for complex I inhibition and the decrease in ATP intracellular contents caused by TEBU. Secretion of the 20 S circulating proteasome and overall inhibition of acute inflammation followed by IL-6 secretion in later stages were observed in HepaRG cells. These effects were associated with a decrease in STAT1 and STAT3 transcription factor abundances, but with different kinetics. Based on identified TEBU targets, docking experiments, and nuclear receptor reporter assays, we concluded that liver cell response to TEBU is mediated by its interaction with the PPARγ transcription factor.
- Published
- 2023
- Full Text
- View/download PDF